Hologic [HOLX] vs Alcon [ALC] Detailed Stock Comparison
Hologic
NASDAQ
Loading...
Alcon
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Hologic wins in 13 metrics, Alcon wins in 6 metrics, with 0 ties. Hologic appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Hologic | Alcon | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 28.24 | 40.84 | Hologic |
| Price-to-Book Ratio | 3.12 | 2.07 | Alcon |
| Debt-to-Equity Ratio | 52.09 | 23.63 | Alcon |
| PEG Ratio | 14.42 | 26.11 | Hologic |
| EV/EBITDA | 12.64 | 21.16 | Hologic |
| Profit Margin (TTM) | 13.79% | 11.28% | Hologic |
| Operating Margin (TTM) | 25.48% | 13.30% | Hologic |
| EBITDA Margin (TTM) | 25.48% | 13.30% | Hologic |
| Return on Equity | 11.38% | 5.23% | Hologic |
| Return on Assets (TTM) | 6.69% | 2.74% | Hologic |
| Free Cash Flow (TTM) | $1.15B | $1.41B | Alcon |
| 1-Year Return | -18.63% | -7.72% | Alcon |
| Price-to-Sales Ratio (TTM) | 3.75 | 4.62 | Hologic |
| Enterprise Value | $15.78B | $49.36B | Alcon |
| EV/Revenue Ratio | 3.91 | 4.97 | Hologic |
| Gross Profit Margin (TTM) | 56.32% | 55.92% | Hologic |
| Revenue per Share (TTM) | $18 | $20 | Alcon |
| Earnings per Share (Diluted) | $2.41 | $2.25 | Hologic |
| Beta (Stock Volatility) | 0.49 | 0.70 | Hologic |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Hologic vs Alcon Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Hologic | 0.19% | 1.34% | 4.87% | 21.15% | 4.32% | -5.13% |
| Alcon | 0.35% | -2.41% | -1.49% | -10.57% | -3.95% | 2.76% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Hologic | -18.63% | -6.75% | 1.87% | 60.33% | 361.11% | 493.89% |
| Alcon | -7.72% | 22.38% | 39.36% | 57.54% | 57.54% | 57.54% |
Performance & Financial Health Analysis: Hologic vs Alcon
| Metric | HOLX | ALC |
|---|---|---|
| Market Information | ||
| Market Cap | $15.14B | $45.84B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,889,880 | 1,498,680 |
| 90 Day Avg. Volume | 1,864,063 | 1,604,603 |
| Last Close | $68.06 | $85.75 |
| 52 Week Range | $51.90 - $84.67 | $80.48 - $101.10 |
| % from 52W High | -19.62% | -15.18% |
| All-Time High | $87.88 (May 01, 2023) | $101.10 (Sep 09, 2024) |
| % from All-Time High | -22.55% | -15.18% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.01% | 0.01% |
| Quarterly Earnings Growth | 0.00% | 0.41% |
| Financial Health | ||
| Profit Margin (TTM) | 0.14% | 0.11% |
| Operating Margin (TTM) | 0.25% | 0.13% |
| Return on Equity (TTM) | 0.11% | 0.05% |
| Debt to Equity (MRQ) | 52.09 | 23.63 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $21.79 | $44.39 |
| Cash per Share (MRQ) | $8.47 | $2.85 |
| Operating Cash Flow (TTM) | $1.07B | $2.12B |
| Levered Free Cash Flow (TTM) | $760.11M | $1.18B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Hologic vs Alcon
| Metric | HOLX | ALC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 28.24 | 40.84 |
| Forward P/E | 14.42 | 26.11 |
| PEG Ratio | 14.42 | 26.11 |
| Price to Sales (TTM) | 3.75 | 4.62 |
| Price to Book (MRQ) | 3.12 | 2.07 |
| Market Capitalization | ||
| Market Capitalization | $15.14B | $45.84B |
| Enterprise Value | $15.78B | $49.36B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.91 | 4.97 |
| Enterprise to EBITDA | 12.64 | 21.16 |
| Risk & Other Metrics | ||
| Beta | 0.49 | 0.70 |
| Book Value per Share (MRQ) | $21.79 | $44.39 |
Financial Statements Comparison: Hologic vs Alcon
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HOLX | ALC |
|---|---|---|
| Revenue/Sales | $1.01B | $2.47B |
| Cost of Goods Sold | $628.00M | $1.09B |
| Gross Profit | $377.30M | $1.38B |
| Research & Development | $61.50M | $222.00M |
| Operating Income (EBIT) | $37.90M | $468.00M |
| EBITDA | $121.70M | $463.00M |
| Pre-Tax Income | $-28.50M | $414.00M |
| Income Tax | $-11.10M | $64.00M |
| Net Income (Profit) | $-17.40M | $350.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HOLX | ALC |
|---|---|---|
| Cash & Equivalents | $1.43B | $1.41B |
| Total Current Assets | $3.21B | $6.07B |
| Total Current Liabilities | $989.70M | $2.25B |
| Long-Term Debt | $2.47B | $5.02B |
| Total Shareholders Equity | $4.62B | $22.02B |
| Retained Earnings | $3.03B | N/A |
| Property, Plant & Equipment | $939.80M | $4.90B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HOLX | ALC |
|---|---|---|
| Operating Cash Flow | $28.40M | N/A |
| Capital Expenditures | $-24.70M | N/A |
| Free Cash Flow | $129.20M | $384.00M |
| Debt Repayment | $-10.20M | N/A |
| Common Stock Repurchase | $-200.00M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | HOLX | ALC |
|---|---|---|
| Shares Short | 5.15M | 6.89M |
| Short Ratio | 2.16 | 4.54 |
| Short % of Float | 0.03% | N/A |
| Average Daily Volume (10 Day) | 1,889,880 | 1,498,680 |
| Average Daily Volume (90 Day) | 1,864,063 | 1,604,603 |
| Shares Outstanding | 231.73M | 494.62M |
| Float Shares | 220.31M | 494.60M |
| % Held by Insiders | 0.01% | 0.00% |
| % Held by Institutions | 1.03% | 0.69% |
Dividend Analysis & Yield Comparison: Hologic vs Alcon
| Metric | HOLX | ALC |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.17 |
| 3-Year Avg Dividend Yield | N/A | 0.30% |
| 3-Year Total Dividends | N/A | $0.50 |
| Ex-Dividend Date | N/A | May 14, 2024 |